FOLD logo

Amicus Therapeutics (FOLD) Shareholders equity

annual shareholders equity:

$194.04M+$33.87M(+21.15%)
December 31, 2024

Summary

  • As of today (May 24, 2025), FOLD annual stockholders equity is $194.04 million, with the most recent change of +$33.87 million (+21.15%) on December 31, 2024.
  • During the last 3 years, FOLD annual shareholders equity has fallen by -$113.32 million (-36.87%).
  • FOLD annual shareholders equity is now -59.27% below its all-time high of $476.43 million, reached on December 31, 2019.

Performance

FOLD Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

quarterly shareholders equity:

$193.56M-$487.00K(-0.25%)
March 31, 2025

Summary

  • As of today (May 24, 2025), FOLD quarterly stockholders equity is $193.56 million, with the most recent change of -$487.00 thousand (-0.25%) on March 31, 2025.
  • Over the past year, FOLD quarterly shareholders equity has increased by +$62.86 million (+48.10%).
  • FOLD quarterly shareholders equity is now -67.74% below its all-time high of $600.06 million, reached on June 30, 2019.

Performance

FOLD quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherFOLDbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

FOLD Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.1%+48.1%
3 y3 years-36.9%-18.9%
5 y5 years-59.3%-51.9%

FOLD Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-36.9%+57.7%-18.9%+88.7%
5 y5-year-59.3%+57.7%-51.9%+88.7%
alltimeall time-59.3%+350.3%-67.7%+324.3%

FOLD Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$193.56M(-0.3%)
Dec 2024
$194.04M(+21.1%)
$194.04M(+8.5%)
Sep 2024
-
$178.82M(+34.9%)
Jun 2024
-
$132.52M(+1.4%)
Mar 2024
-
$130.69M(-18.4%)
Dec 2023
$160.17M(+30.2%)
$160.17M(+20.2%)
Sep 2023
-
$133.24M(+19.4%)
Jun 2023
-
$111.58M(+8.8%)
Mar 2023
-
$102.57M(-16.6%)
Dec 2022
$123.05M(-60.0%)
$123.05M(-7.2%)
Sep 2022
-
$132.56M(-23.6%)
Jun 2022
-
$173.43M(-27.3%)
Mar 2022
-
$238.62M(-22.4%)
Dec 2021
$307.37M(+7.3%)
$307.37M(-18.4%)
Sep 2021
-
$376.63M(+76.1%)
Jun 2021
-
$213.91M(-14.7%)
Mar 2021
-
$250.90M(-12.4%)
Dec 2020
$286.38M(-39.9%)
$286.38M(-10.6%)
Sep 2020
-
$320.27M(-11.3%)
Jun 2020
-
$360.95M(-10.3%)
Mar 2020
-
$402.59M(-15.5%)
Dec 2019
$476.43M(+38.9%)
$476.43M(-13.1%)
Sep 2019
-
$548.27M(-8.6%)
Jun 2019
-
$600.06M(+32.9%)
Mar 2019
-
$451.67M(+31.7%)
Dec 2018
$342.91M(-2.8%)
$342.91M(-16.6%)
Sep 2018
-
$410.95M(-26.9%)
Jun 2018
-
$561.89M(+7.7%)
Mar 2018
-
$521.62M(+47.8%)
Dec 2017
$352.85M(-2.0%)
$352.85M(-13.9%)
Sep 2017
-
$409.68M(+53.5%)
Jun 2017
-
$266.89M(-14.1%)
Mar 2017
-
$310.78M(-13.7%)
Dec 2016
$360.15M(+3.5%)
$360.15M(+7.0%)
Sep 2016
-
$336.56M(+0.7%)
Jun 2016
-
$334.24M(+7.3%)
Mar 2016
-
$311.63M(-10.4%)
Dec 2015
$347.83M
$347.83M(-8.2%)
DateAnnualQuarterly
Sep 2015
-
$378.75M(+15.2%)
Jun 2015
-
$328.90M(+216.2%)
Mar 2015
-
$104.01M(-14.9%)
Dec 2014
$122.18M(+167.0%)
$122.18M(+182.3%)
Sep 2014
-
$43.28M(+19.2%)
Jun 2014
-
$36.31M(+16.8%)
Mar 2014
-
$31.08M(-32.1%)
Dec 2013
$45.75M(-33.9%)
$45.75M(+72.7%)
Sep 2013
-
$26.49M(-33.0%)
Jun 2013
-
$39.56M(-25.8%)
Mar 2013
-
$53.34M(-22.9%)
Dec 2012
$69.22M(+133.9%)
$69.22M(-9.8%)
Sep 2012
-
$76.76M(+4.9%)
Jun 2012
-
$73.17M(-9.4%)
Mar 2012
-
$80.78M(+173.0%)
Dec 2011
$29.59M(-54.4%)
$29.59M(-19.6%)
Sep 2011
-
$36.79M(-17.5%)
Jun 2011
-
$44.61M(-15.9%)
Mar 2011
-
$53.06M(-18.3%)
Dec 2010
$64.93M(-9.6%)
$64.93M(+28.6%)
Sep 2010
-
$50.49M(-21.6%)
Jun 2010
-
$64.36M(-13.3%)
Mar 2010
-
$74.19M(+3.3%)
Dec 2009
$71.83M(+1.1%)
$71.83M(+93.3%)
Sep 2009
-
$37.16M(-23.6%)
Jun 2009
-
$48.64M(-19.3%)
Mar 2009
-
$60.26M(-15.2%)
Dec 2008
$71.04M(-31.2%)
$71.04M(-14.4%)
Sep 2008
-
$83.02M(-7.4%)
Jun 2008
-
$89.67M(-8.2%)
Mar 2008
-
$97.69M(-5.4%)
Dec 2007
$103.30M(-233.3%)
$103.30M(-9.1%)
Sep 2007
-
$113.69M(-7.3%)
Jun 2007
-
$122.67M(-242.2%)
Mar 2007
-
-$86.28M(+11.3%)
Dec 2006
-$77.52M(+116.3%)
-$77.52M(+116.3%)
Dec 2005
-$35.83M(+579.2%)
-$35.83M
Dec 2003
-$5.28M
-

FAQ

  • What is Amicus Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Amicus Therapeutics?
  • What is Amicus Therapeutics annual shareholders equity year-on-year change?
  • What is Amicus Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly shareholders equity year-on-year change?

What is Amicus Therapeutics annual stockholders equity?

The current annual shareholders equity of FOLD is $194.04M

What is the all time high annual shareholders equity for Amicus Therapeutics?

Amicus Therapeutics all-time high annual stockholders equity is $476.43M

What is Amicus Therapeutics annual shareholders equity year-on-year change?

Over the past year, FOLD annual stockholders equity has changed by +$33.87M (+21.15%)

What is Amicus Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of FOLD is $193.56M

What is the all time high quarterly shareholders equity for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly stockholders equity is $600.06M

What is Amicus Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, FOLD quarterly stockholders equity has changed by +$62.86M (+48.10%)
On this page